
Recently, a novel concept of IgG4-related disease (IgG4-RD), which shows increased serum IgG4/IgE levels, abundant infiltration of IgG4+plasmacytes and lymphocytes, fibrosis, and steroid responsiveness, has been worldwide accepted. The international consensus diagnostic criteria suggested the existence of two subtypes of autoimmune pancreatitis (AIP) : type 1 related with IgG4, and type 2 related with a granulocytic epithelial lesion. Before the IgG4-era, most of IgG4-SC cases were misdiagnosed as primary sclerosing cholangitis (PSC). Now, type 1 AIP and IgG4-sclerosing cholangitis (IgG4-SC) are defined as pancreatic and biliary manifestations of IgG4-RD, individually. Inflammatory bowel disease is often associated with type 2 AIP and PSC, but not Iwith type 1 or IgG4-SC. Steroid treatment is effective for IgG4-RD, but the long-term outcome still remains unclear.
Regulatory T cells (Tregs) expressing the transcription factor Foxp3 play a crucial role in maintaining peripheral immune tolerance and preventing autoimmunity. With being abun- dant in tumor tissue, they promote tumor progression by suppressing effective antitumor im- munity. Additionally, recent progresses suggest that Tregs comprise functionally distinct subsets and contribute differently to cancer prognosis. Thus, there has been considerable interest in integration of strategies restricting Tregs-mediated immune suppression by selec- tively reducing Tregs or attenuating their suppressive activity with activating tumor-specific effector T cells. Understanding mechanisms for abundance of Tregs in tumors is crucial for developing optimal Tregs-mediated immunotherapy.
Although many disorders are included in secondary parkinsonism, the mechanisms underlying parkinsonism vary and have yet to be elucidated. Herein, we introduced a group of diseases included among the forms of secondary parkinsonism and provide overviews of clinically significant drug-induced parkinsonism (DIP), vascular parkinson- ism (VP), and idiopathic normal pressure hydrocephalus (iNPH) with a focus on pathophysiology and symptoms. Although DIP has the highest frequency among the forms of secondary parkinsonism, it is overlooked in many patients due to lack of knowledge about drugs by the prescribing physicians. Both VP and iNPH present with "lower body parkinsonism, " showing the characteristic gait disturbance. DIP and iNPH are treatable, highlighting the importance of early diagnosis and treatment intervention.
Autonomic symptoms affect most patients with Parkinson's disease (PD) and often have a profound impact on their prognosis. Symptoms include orthostatic hypotension, gastroparesis, constipation, excessive sweating, and sexual dysfunction, however, these symptoms are frequently unrecognised by clinicians and remain untreated. The mechanism of autonomic dysfunction is attributed to the involvement of the central and peripheral postganglionic nervous system. It is now well established some autonomic symptoms have a diagnostic value because they appear early in the course of PD and may precede the onset of motor symptoms. Early recognition of autonomic symptoms is essential because it will help to expand our knowledge of the nature the neurodegenera- tive process. It is important that physicians both recognize and treat theses complications in an effort to improve quality of life.
The causes of IBD (inflammatory bowel disease), ulcerative colitis and Crohn's disease, have not been elucidated. It is thought that the pathogenesis involves genetic predisposition, environmental factors and host immune response to food antigens and microbiota. Most of IBD susceptiblity genes are related to function of immune cells, maintenance of homeostasis of epithelial cells, autophagy, ER stress and so on. These genetic abnormalities may induce abnormal immune response to antigens and intestinal bacteria, which are modified by diet habit and hygiene environment. Recently, the interrelationship between intestinal bacteria and hosts has dramatically been elucidated, and breakdown of the homeostatic mechanisms at the cellular level is revealed to have an important role in the onset of IBD.